Insomnia Treatment Market : Table of Content


  • Published On : Jun-2018 |
  • Pages : 163 Pages |
  • Format : Insomnia Treatment Market Insomnia Treatment Market Insomnia Treatment Market Insomnia Treatment Market

1. Executive Summary
     1.1. Market Overview
     1.2. Market Analysis
     1.3. PMR Analysis and Recommendations
     1.4. Wheel of Fortune

2. Market Introduction
     2.1. Market Definition
     2.2. Market Taxonomy
     2.3. Inclusion and Exclusion

3. Market Dynamics
     3.1. Macro-Economic Factors
     3.2. Drivers
     3.3. Restraints
     3.4. Opportunity Analysis
     3.5. Trends

4. Macroeconomic Assumptions

5. Global Economic Outlook
     5.1. Gross Domestic Product by Region & Country, 2006 – 2021
     5.2. Healthcare Sector Outlook
     5.3. Healthcare Indicators

6. Key Inclusions
     6.1. Epidemiology of Insomnia, By Region

7. North America Insomnia Treatment Market Analysis 2013–2017 and Forecast 2018–2026
     7.1. Introduction
     7.2. Regional Market Trends
     7.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013–2017
            7.3.1. U.S.
            7.3.2. Canada
     7.4. Market Size (US$ Mn) Forecast By Country, 2018–2026
     7.5. Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013–2017
            7.5.1. OTC Drugs
                     7.5.1.1. OTC Sleep Aids
                     7.5.1.2. OTC Sleep Supplements
            7.5.2. Prescription Drugs
     7.6. Market Size (US$ Mn) Forecast By Drug Type, 2018–2026
     7.7. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
            7.7.1. Hospital Pharmacies
            7.7.2. Retail Pharmacies
            7.7.3. e commerce
            7.7.4. Drug Stores
            7.7.5. Others
     7.8. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2026
     7.9. Market Attractiveness Analysis
            7.9.1. By Country
            7.9.2. By Drug Type
            7.9.3. By Distribution Channel

8. Latin America Insomnia Treatment Market Analysis 2013–2017 and Forecast 2018–2026
     8.1. Introduction
     8.2. Regional Market Trends
     8.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013–2017
            8.3.1. Argentina
            8.3.2. Brazil
            8.3.3. Mexico
            8.3.4. Rest of Latin America
     8.4. Market Size (US$ Mn) Forecast By Country, 2018–2026
     8.5. Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013–2017
            8.5.1. OTC Drugs
                     8.5.1.1. OTC Sleep Aids
                     8.5.1.2. OTC Sleep Supplements
            8.5.2. Prescription Drugs
     8.6. Market Size (US$ Mn) Forecast By Drug Type, 2018–2026
     8.7. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
            8.7.1. Hospital Pharmacies
            8.7.2. Retail Pharmacies
            8.7.3. e commerce
            8.7.4. Drug Stores
            8.7.5. Others
     8.8. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2026
     8.9. Market Attractiveness Analysis
            8.9.1. By Country
            8.9.2. By Drug Type
            8.9.3. By Distribution Channel

9. Europe Insomnia Treatment Market Analysis 2013–2017 and Forecast 2018–2026
     9.1. Introduction
     9.2. Regional Market Trends
     9.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013–2017
            9.3.1. Germany
            9.3.2. U.K.
            9.3.3. France
            9.3.4. Italy
            9.3.5. Spain
            9.3.6. Russia
            9.3.7. Poland
            9.3.8. Rest of Europe
     9.4. Market Size (US$ Mn) Forecast By Country, 2018–2026
     9.5. Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013–2017
            9.5.1. OTC Drugs
                     9.5.1.1. OTC Sleep Aids
                     9.5.1.2. OTC Sleep Supplements
            9.5.2. Prescription Drugs
     9.6. Market Size (US$ Mn) Forecast By Drug Type, 2018–2026
     9.7. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
            9.7.1. Hospital Pharmacies
            9.7.2. Retail Pharmacies
            9.7.3. e commerce
            9.7.4. Drug Stores
            9.7.5. Others
     9.8. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2026
     9.9. Market Attractiveness Analysis
            9.9.1. By Country
            9.9.2. By Drug Type
            9.9.3. By Distribution Channel

10. Asia Pacific Insomnia Treatment Market Analysis 2013–2017 and Forecast 2018–2026
     10.1.Introduction
     10.2.Regional Market Trends
     10.3.Historical Market Size (US$ Mn) Trend Analysis By Country, 2013–2017
            10.3.1. China
            10.3.2. Japan
            10.3.3. India
            10.3.4. Australia and New Zealand
            10.3.5. ASEAN
            10.3.6. Rest of Asia Pacific
     10.4.Market Size (US$ Mn) Forecast By Country, 2018–2026
     10.5.Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013–2017
            10.5.1. OTC Drugs
                     10.5.1.1. OTC Sleep Aids
                     10.5.1.2. OTC Sleep Supplements
            10.5.2. Prescription Drugs
     10.6.Market Size (US$ Mn) Forecast By Drug Type, 2018–2026
     10.7.Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
            10.7.1. Hospital Pharmacies
            10.7.2. Retail Pharmacies
            10.7.3. e commerce
            10.7.4. Drug Stores
            10.7.5. Others
     10.8.Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2026
     10.9.Market Attractiveness Analysis
            10.9.1. By Country
            10.9.2. By Drug Type
            10.9.3. By Distribution Channel

11. Middle East & Africa Insomnia Treatment Market Analysis 2013–2017 and Forecast 2018–2026
     11.1.Introduction
     11.2.Key Regulations
     11.3.Historical Market Size (US$ Mn) Trend Analysis By Country, 2013–2017
            11.3.1. GCC Countries
            11.3.2. South Africa
            11.3.3. Rest of MEA
     11.4.Market Size (US$ Mn) Forecast By Country, 2018–2026
     11.5.Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013–2017
            11.5.1. OTC Drugs
                     11.5.1.1. OTC Sleep Aids
                     11.5.1.2. OTC Sleep Supplements
            11.5.2. Prescription Drugs
     11.6.Market Size (US$ Mn) Forecast By Drug Type, 2018–2026
     11.7.Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
            11.7.1. Hospital Pharmacies
            11.7.2. Retail Pharmacies
            11.7.3. e commerce
            11.7.4. Drug Stores
            11.7.5. Others
     11.8.Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2026
     11.9.Market Attractiveness Analysis
            11.9.1. By Country
            11.9.2. By Drug Type
            11.9.3. By Distribution Channel

12. Forecast Factors: Relevance and Impact

13. Competition Analysis
     13.1.Competition Dashboard
     13.2.Competition Benchmarking
     13.3.Profitability and Gross Margin Analysis By Competition
     13.4.Company Deep Dive
            13.4.1. Merck & Co. Inc.
                     13.4.1.1. Overview
                     13.4.1.2. Product and Technology Portfolio
                     13.4.1.3. Production Footprint
                     13.4.1.4. Sales Footprint
                     13.4.1.5. Channel Footprint
                     13.4.1.6. Strategy
                                13.4.1.6.1.1. Marketing Strategy
                                13.4.1.6.1.2. Product Strategy
                                13.4.1.6.1.3. Channel Strategy
            13.4.2. Natrol, LLC
                     13.4.2.1. Overview
                     13.4.2.2. Product and Technology Portfolio
                     13.4.2.3. Production Footprint
                     13.4.2.4. Sales Footprint
                     13.4.2.5. Channel Footprint
                     13.4.2.6. Strategy
                                13.4.2.6.1.1. Marketing Strategy
                                13.4.2.6.1.2. Product Strategy
                                13.4.2.6.1.3. Channel Strategy
            13.4.3. GlaxoSmithKline Plc.
                     13.4.3.1. Overview
                     13.4.3.2. Product and Technology Portfolio
                     13.4.3.3. Production Footprint
                     13.4.3.4. Sales Footprint
                     13.4.3.5. Channel Footprint
                     13.4.3.6. Strategy
                                13.4.3.6.1.1. Marketing Strategy
                                13.4.3.6.1.2. Product Strategy
                                13.4.3.6.1.3. Channel Strategy
            13.4.4. Sanofi SA
                     13.4.4.1. Overview
                     13.4.4.2. Product and Technology Portfolio
                     13.4.4.3. Production Footprint
                     13.4.4.4. Sales Footprint
                     13.4.4.5. Channel Footprint
                     13.4.4.6. Strategy
                                13.4.4.6.1.1. Marketing Strategy
                                13.4.4.6.1.2. Product Strategy
                                13.4.4.6.1.3. Channel Strategy
            13.4.5. Pfizer Inc.
                     13.4.5.1. Overview
                     13.4.5.2. Product and Technology Portfolio
                     13.4.5.3. Production Footprint
                     13.4.5.4. Sales Footprint
                     13.4.5.5. Channel Footprint
                     13.4.5.6. Strategy
                                13.4.5.6.1.1. Marketing Strategy
                                13.4.5.6.1.2. Product Strategy
                                13.4.5.6.1.3. Channel Strategy
            13.4.6. Boehringer Ingelheim International GmbH
                     13.4.6.1. Overview
                     13.4.6.2. Product and Technology Portfolio
                     13.4.6.3. Production Footprint
                     13.4.6.4. Sales Footprint
                     13.4.6.5. Channel Footprint
                     13.4.6.6. Strategy
                                13.4.6.6.1.1. Marketing Strategy
                                13.4.6.6.1.2. Product Strategy
                                13.4.6.6.1.3. Channel Strategy
            13.4.7. Mallinckrodt
                     13.4.7.1. Overview
                     13.4.7.2. Product and Technology Portfolio
                     13.4.7.3. Production Footprint
                     13.4.7.4. Sales Footprint
                     13.4.7.5. Channel Footprint
                     13.4.7.6. Strategy
                                13.4.7.6.1.1. Marketing Strategy
                                13.4.7.6.1.2. Product Strategy
                                13.4.7.6.1.3. Channel Strategy
            13.4.8. PERNIX Therapeutics
                     13.4.8.1. Overview
                     13.4.8.2. Product and Technology Portfolio
                     13.4.8.3. Production Footprint
                     13.4.8.4. Sales Footprint
                     13.4.8.5. Channel Footprint
                     13.4.8.6. Strategy
                                13.4.8.6.1.1. Marketing Strategy
                                13.4.8.6.1.2. Product Strategy
                                13.4.8.6.1.3. Channel Strategy
            13.4.9. Takeda Pharmaceutical Company Limited
                     13.4.9.1. Overview
                     13.4.9.2. Product and Technology Portfolio
                     13.4.9.3. Production Footprint
                     13.4.9.4. Sales Footprint
                     13.4.9.5. Channel Footprint
                     13.4.9.6. Strategy
                                13.4.9.6.1.1. Marketing Strategy
                                13.4.9.6.1.2. Product Strategy
                                13.4.9.6.1.3. Channel Strategy
            13.4.10. Sunovion Pharmaceuticals, Inc.
                     13.4.10.1. Overview
                     13.4.10.2. Product and Technology Portfolio
                     13.4.10.3. Production Footprint
                     13.4.10.4. Sales Footprint
                     13.4.10.5. Channel Footprint
                     13.4.10.6. Strategy
                                13.4.10.6.1.1.  Marketing Strategy
                                13.4.10.6.1.2.  Product Strategy
                                13.4.10.6.1.3.  Channel Strategy

14. Global Insomnia Treatment Market Analysis 2013–2017 and Forecast 2018–2026, By Region
     14.1.Introduction/Key Findings
     14.2.Historical Market Size (US$ Mn)Trend Analysis By Region, 2013–2017
     14.3.Market Size (US$ Mn) Forecast By Region, 2018–2026
            14.3.1. North America
            14.3.2. Latin America
            14.3.3. Europe
            14.3.4. Asia Pacific Excluding China
            14.3.5. China
            14.3.6. Middle East & Africa
     14.4.Market Attractiveness Analysis By Region

15. Global Insomnia Treatment Analysis 2013–2017 and Forecast 2018–2026, By Drug Type
     15.1.Introduction/Key Findings
     15.2.Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013–2017
            15.2.1. OTC Drugs
                     15.2.1.1. OTC Sleep Aids
                     15.2.1.2. OTC Sleep Supplements
            15.2.2. Prescription Drugs
     15.3.Market Size (US$ Mn) Forecast By Drug Type, 2018–2026
     15.4.Market Attractiveness Analysis By Drug Type

16. Global Insomnia Treatment Market Analysis 2013–2017 and Forecast 2018–2026, By Distribution Channel
     16.1.Introduction/Key Findings
     16.2.Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
            16.2.1. Hospital Pharmacies
            16.2.2. Retail Pharmacies
            16.2.3. e commerce
            16.2.4. Drug Stores
            16.2.5. Others
     16.3.Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2026
     16.4.Market Attractiveness Analysis By Distribution Channel

17. Global Insomnia Treatment Market Analysis 2013–2017 and Forecast 2018–2026
     17.1.Market Value Share Analysis
     17.2.Y-o-Y Growth Analysis
     17.3.Absolute $ Opportunity

18. Research Methodology


List of Tables

Table 01: Expenditure on Health, (% of GDP), by Country, 2016 - 2021
Table 02: Expenditure on Health, (% of GDP), by Country, 2016 - 2021
Table 03: North America Insomnia Treatment Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 04: North America Insomnia Treatment Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Type
Table 05: North America Insomnia Treatment Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel
Table 06: Latin America Insomnia Treatment Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 07: Latin America Insomnia Treatment Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Type
Table 08: Latin America Insomnia Treatment Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel
Table 09: Europe Insomnia Treatment Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 10: Europe Insomnia Treatment Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Type
Table 11: Europe Insomnia Treatment Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel
Table 12: Asia Pacific Insomnia Treatment Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 13: Asia Pacific Insomnia Treatment Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Type
Table 14: Asia Pacific Insomnia Treatment Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel
Table 15: Middle East and Africa Insomnia Treatment Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 16: Middle East and Africa Insomnia Treatment Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Type
Table 17: Middle East and Africa Insomnia Treatment Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel
Table 18: Global Sleep Aids Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Region
Table 19: Global Sleep Aids Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Type
Table 20: Global Sleep Aids Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel


List of Figures

Figure 01: Country wise Prevalence of Insomnia, 2016
Figure 02: Percentage of adults aged 20 and over using prescription sleep aids, by age: United States, 2005–2010
Figure 03: Global Healthcare Expenditure in US$ Tn (2013–2020)
Figure 04: North America Insomnia Treatment Market Value Share (2017A), By Drug Type , Distribution Channel and Country
Figure 05: North America Insomnia Treatment Market Size (US$ Mn) Analysis, 2013-2017
Figure 06: North America Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026
Figure 07: North America Insomnia Treatment Market Y-o-Y growth (%) Comparison, By Country, 2018-2026
Figure 08: U.S. Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 09: U.S. Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2026
Figure 10: Canada Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 11: Canada Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2026
Figure 12: North America Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017, By OTC Drugs
Figure 13: North America Insomnia Treatment Market Size (US$ Mn)  & Y-o-Y Growth (%), 2018–2026, By OTC Drugs
Figure 14: North America Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017, By Prescription Drugs
Figure 15: North America Insomnia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Prescription Drugs
Figure 16: North America Insomnia Treatment Market Attractiveness Analysis, By Country
Figure 17: North America Insomnia Treatment Market Attractiveness Analysis, By Drug Type
Figure 18: North America Insomnia Treatment Market Attractiveness Analysis, By Distribution Channel
Figure 19: Latin America Insomnia Treatment Market Value Share (2017A), By Drug Type , Distribution Channel and Country
Figure 20: Latin America Insomnia Treatment Market Size (US$ Mn) Analysis, 2013-2017
Figure 21: Latin America Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026
Figure 22: Latin America Insomnia Treatment Market Y-o-Y growth (%) Comparison, By Country, 2018-2026
Figure 23: Brazil Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 24: Brazil Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2026
Figure 25: Mexico Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 26:  Mexico Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2026
Figure 27: Rest of Latin America Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 28: Rest of Latin America Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2026
Figure 29: Latin America Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017, By OTC Drugs
Figure 30: Latin America Insomnia Treatment Market Size (US$ Mn)  & Y-o-Y Growth (%), 2018–2026, By OTC Drugs
Figure 31: Latin America Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017, By Prescription Drugs
Figure 32: Latin America Insomnia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Prescription Drugs
Figure 33: Latin America Insomnia Treatment Market Attractiveness Analysis, By Country
Figure 34: Latin America Insomnia Treatment Market Attractiveness Analysis, By Drug Type
Figure 35: Latin America Insomnia Treatment Market Attractiveness Analysis, By Distribution Channel
Figure 36: Europe Insomnia Treatment Market Value Share (2017A), By Drug Type , Distribution Channel and Country
Figure 37: Europe Insomnia Treatment Market Size (US$ Mn) Analysis, 2013-2017
Figure 38: Europe Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026
Figure 39: Europe Insomnia Treatment Market Y-o-Y growth (%) Comparison, By Country, 2018-2026
Figure 40: Germany Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 41: Germany Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2026
Figure 42: U.K. Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 43: U.K. Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2026
Figure 44: France Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 45: France Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2026
Figure 46: Italy Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 47: Italy Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2026
Figure 48: Spain Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 49: Spain Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2026
Figure 50: Russia Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 51: Russia Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2026
Figure 52: Poland Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 53: Poland Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2026
Figure 54: Rest of Europe Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 55: Rest of Europe Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2026
Figure 56: Europe Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017, By OTC Drugs
Figure 57: Europe Insomnia Treatment Market Size (US$ Mn)  & Y-o-Y Growth (%), 2018–2026, By OTC Drugs
Figure 58: Europe Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017, By Prescription Drugs
Figure 59: Europe Insomnia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Prescription Drugs
Figure 60: Europe Insomnia Treatment Market Attractiveness Analysis, By Country
Figure 61: Europe Insomnia Treatment Market Attractiveness Analysis, By Drug Type
Figure 62: Europe Insomnia Treatment Market Attractiveness Analysis, By Distribution Channel
Figure 63: Asia Pacific Insomnia Treatment Market Value Share (2017A), By Drug Type , Distribution Channel and Country
Figure 64: Asia Pacific Insomnia Treatment Market Size (US$ Mn) Analysis, 2013-2017
Figure 65: Asia Pacific Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026
Figure 66: Asia Pacific Insomnia Treatment Market Y-o-Y growth (%) Comparison, By Country, 2018-2026
Figure 67: China Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 68: China Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2026
Figure 69: India Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 70: India Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2026
Figure 71: Japan Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 72: Japan Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2026
Figure 73: Australia & New Zealand Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 74: Australia & New Zealand Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2026
Figure 75: ASEAN Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 76: ASEAN Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2026
Figure 77: Rest of Asia Pacific Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 78: Rest of Asia Pacific Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2026
Figure 79: Asia Pacific Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017, By OTC Drugs
Figure 80: Asia Pacific Insomnia Treatment Market Size (US$ Mn)  & Y-o-Y Growth (%), 2018–2026, By OTC Drugs
Figure 81: Asia Pacific Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017, By Prescription Drugs
Figure 82: Asia Pacific Insomnia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Prescription Drugs
Figure 83: Asia Pacific Insomnia Treatment Market Attractiveness Analysis, By Country
Figure 84: Asia Pacific Insomnia Treatment Market Attractiveness Analysis, By Drug Type
Figure 85: Asia Pacific Insomnia Treatment Market Attractiveness Analysis, By Distribution Channel
Figure 86: Middle East and Africa Insomnia Treatment Market Value Share (2017A), By Drug Type , Distribution Channel and Country
Figure 87: Middle East and Africa Insomnia Treatment Market Size (US$ Mn) Analysis, 2013-2017
Figure 88: Middle East and Africa Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026
Figure 89: Middle East and Africa Insomnia Treatment Market Y-o-Y growth (%) Comparison, By Country, 2018-2026
Figure 90: GCC Countries Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 91: GCC Countries Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2026
Figure 92: South Africa Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 93: South Africa Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2026
Figure 94: Rest of MEA Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 95: Rest of MEA Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2026
Figure 96: Middle East and Africa Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017, By OTC Drugs
Figure 97: Middle East and Africa Insomnia Treatment Market Size (US$ Mn)  & Y-o-Y Growth (%), 2018–2026, By OTC Drugs
Figure 98: Middle East and Africa Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017, By Prescription Drugs
Figure 99: Middle East and Africa Insomnia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Prescription Drugs
Figure 100: Middle East and Africa Insomnia Treatment Market Attractiveness Analysis, By Country
Figure 101: Middle East and Africa Insomnia Treatment Market Attractiveness Analysis, By Drug Type
Figure 102: Middle East and Africa Insomnia Treatment Market Attractiveness Analysis, By Distribution Channel
Figure 103: Global Insomnia Treatment Market Attractiveness Analysis, By Region
Figure 104: Global Insomnia Treatment Market Attractiveness Analysis, By Drug Type
Figure 105: Global Insomnia Treatment Market Attractiveness Analysis, By Distribution Channel
Figure 106: Global Insomnia Treatment Market Size and Y-o-Y, 2013 - 2017
Figure 107: Global Insomnia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 108: Global Insomnia Treatment Market Absolute $ Opportunity, 2017–2026

Insomnia Treatment Market - Table of Content

Back To Top